Elotuzumab,lenalidomide,dexamethasone
Bms
excellent presentation by on immune cell changes in hr-smm patients treated with elo/len/dex #ims22 
Hematologist/Oncologist | Myeloma Physician/Clinical Investigator | @danafarber @harvardmed #multiplemyeloma #mmsm